Cough News and Research RSS Feed - Cough News and Research

Home non-invasive ventilation for COPD: an interview with Dr Holger Woehrle

Home non-invasive ventilation for COPD: an interview with Dr Holger Woehrle

The key symptom of COPD is breathlessness, especially during daily activity, and the breathlessness is in addition to cough and chest tightness. The difficulty in managing this disease is that it's a disease that progresses with age. [More]
Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

Study assesses accuracy of COPD diagnoses and utilization of spirometry in primary care clinics

According to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease for chronic obstructive pulmonary disease (COPD), spirometry should be performed to establish the diagnosis of COPD in any patient who has a history of chronic cough, sputum production, difficulty breathing, or exposure to risk factors. [More]
Dissatisfaction in relationship during pregnancy may increase risk of infection in mother and child

Dissatisfaction in relationship during pregnancy may increase risk of infection in mother and child

Pregnant women dissatisfied in their relationship have an increased risk of infectious diseases. This also affects their children. [More]
Visual cortex plays key role in promoting plasticity of innate, spontaneous eye movements

Visual cortex plays key role in promoting plasticity of innate, spontaneous eye movements

By peering into the eyes of mice and tracking their ocular movements, researchers made an unexpected discovery: the visual cortex - a region of the brain known to process sensory information - plays a key role in promoting the plasticity of innate, spontaneous eye movements. [More]
High indoor temperatures may worsen COPD symptoms

High indoor temperatures may worsen COPD symptoms

High indoor temperatures appear to worsen symptoms of chronic obstructive pulmonary disease, or COPD, particularly in homes that also have high levels of air pollutants, according to new research published in the Annals of the American Thoracic Society. [More]
Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes. [More]
Guidelines for staying healthy during flu season

Guidelines for staying healthy during flu season

The American Academy of Pediatrics updated its annual influenza (flu) season guidelines, withdrawing the child-friendly nasal flu vaccine, FluMist, this year. [More]
Chronic cough different than cough from cold, says allergist

Chronic cough different than cough from cold, says allergist

There's been a lot of talk about politicians and coughs lately. And we've all seen public figures struggle with it. [More]
People in Europe are most skeptical about vaccines

People in Europe are most skeptical about vaccines

The largest ever global survey of attitudes towards vaccines reported today that public confidence in vaccines varies widely between different regions of the world, with European respondents being most sceptical. [More]
New tool could help reduce antibiotic prescribing to children with cough and RTIs

New tool could help reduce antibiotic prescribing to children with cough and RTIs

Respiratory tract infections (RTI) with cough are the most common reason children are prescribed antibiotics by their doctors, but up to a third of prescriptions may be unnecessary. [More]
Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips Respironics, a division of Royal Philips, will showcase its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 in London (September 3-7). [More]
Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Myeloid-derived suppressor cells may serve as biomarkers for idiopathic pulmonary fibrosis

Researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research, have discovered that the number of myeloid-derived suppressor cells (MDSC) is increased in the blood of patients with idiopathic pulmonary fibrosis (IPF). [More]
Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen-Cilag International NV has announced the submission of a Type II variation application to the European Medicines Agency (EMA), seeking to broaden the existing marketing authorisation for the immunotherapy DARZALEX® (daratumumab) to include treatment of adult patients with relapsed multiple myeloma who have received at least one prior therapy. The expanded indication is based on daratumumab in combination with lenalidomide (an immmunomodulatory agent) and dexamethasone, or bortezomib (a PI) and dexamethasone. [More]
New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

New study uses evolutionary theory to predict cancer risk in patients with Barrett's esophagus

A disorder known as Barrett's esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma. [More]
Study explains long-term pulmonary outcomes among childhood cancer survivors

Study explains long-term pulmonary outcomes among childhood cancer survivors

A team of researchers from nine leading academic hospitals and research centers have published a paper in the early online edition of the journal Cancer that describes pulmonary outcomes among childhood cancer survivors. [More]
New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office. [More]
Valley fever diagnosis often overlooked by primary care physicians

Valley fever diagnosis often overlooked by primary care physicians

For patients with pneumonia or ongoing influenza-like symptoms who live in or have visited the west or southwest United States, especially Arizona and central California, infectious diseases experts recommend physicians suspect valley fever, an often-overlooked fungal infection. [More]
Testing lung health online: an interview with Professor Stephen Holgate

Testing lung health online: an interview with Professor Stephen Holgate

In our latest report – The Battle for Breath – the impact of lung disease in the UK, figures suggest that 1 in 5 (around 12.7 million) have been diagnosed with a lung condition in the UK. If you’re over the age of 70, this rises to 1 in 3. [More]
Exposure to infections in early life not linked to higher mortality risk during adulthood

Exposure to infections in early life not linked to higher mortality risk during adulthood

A new biological study by the University of Stirling has found that exposure to infections in early life does not have long-lasting consequences for later-life survival and reproduction. [More]
New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Advertisement
Advertisement